ASPIRA PATHLAB & DIAGNOSTICS
Back to Cashflow Statement
|
ASPIRA PATHLAB & DIAGNOSTICS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Cash Flow from Financing Activities | ₹-0.99 Cr | ₹-0.95 Cr |
What is the latest Cash Flow from Financing Activities ratio of ASPIRA PATHLAB & DIAGNOSTICS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-0.99 Cr |
| Mar2024 | ₹-0.95 Cr |
How is Cash Flow from Financing Activities of ASPIRA PATHLAB & DIAGNOSTICS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.99 Cr | Negative | |
| Mar2024 | ₹-0.95 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ASPIRA PATHLAB & DIAGNOSTICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASPIRA PATHLAB & DIAGNOSTICS | ₹125.7 Cr | 1.3% | 20.2% | 106.3% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹120,956.0 Cr | -0.8% | 5.1% | 21.1% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹106,181.0 Cr | 1.7% | -3.1% | -13.6% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹72,385.4 Cr | -4% | -1.3% | 26.8% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹40,830.5 Cr | -5.9% | 1.5% | 36.6% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹38,172.6 Cr | -1% | -1.3% | 1.5% | Stock Analytics | |
ASPIRA PATHLAB & DIAGNOSTICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASPIRA PATHLAB & DIAGNOSTICS | 1.3% |
20.2% |
106.3% |
| SENSEX | 4.9% |
2.8% |
-6.2% |
You may also like the below Video Courses